Main Management ETF Advisors, LLC Rocket Pharmaceuticals, Inc. Transaction History
Main Management ETF Advisors, LLC
- $2.11 Billion
- Q3 2024
A detailed history of Main Management ETF Advisors, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Main Management ETF Advisors, LLC holds 32,592 shares of RCKT stock, worth $350,038. This represents 0.03% of its overall portfolio holdings.
Number of Shares
32,592Holding current value
$350,038% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding RCKT
# of Institutions
210Shares Held
93.1MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$190 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$121 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$66.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$59.5 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$48.3 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $813M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...